At this time, there is no effective treatment available for this genetic disease, which is the infantile form of a group of progressive, neurometabolic diseases. Doctors at the NIH currently are enrolling children between six months and two years of age for participation in a clinical study of the drug Cystagon for INCL. The study takes place at the NIH in Bethesda, Md. All study-related tests and medicines are provided free of charge.
For more information about this National Institutes of Health (NIH) study, go to www.cc.nih.gov, call (toll free) 1-866-411-1222 (TTY: 1-866-411-1010) or e-mail prpl@cc.nih.gov
Back